Plasma interleukin-1β (IL-1β) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1β concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1β levels may be a marker of panic disorder that is not related to the current level of symptomatology.
Plasma interleukin-1 beta concentrations in panic disorder / F. BRAMBILLA, L. BELLODI, G. PERNA, A. BERTANI, A.E. PANERAI, P. SACERDOTE. - In: PSYCHIATRY RESEARCH. - ISSN 0165-1781. - 54:2(1994), pp. 135-142.
Plasma interleukin-1 beta concentrations in panic disorder
A.E. PANERAIPenultimo
;P. SACERDOTEUltimo
1994
Abstract
Plasma interleukin-1β (IL-1β) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1β concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1β levels may be a marker of panic disorder that is not related to the current level of symptomatology.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
